A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...
According to the study published by Sciencedaily, OLE helps microglia surround and contain beta-amyloid plaques, reducing ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...
A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their protective function against Alzheimer's disease. The study, published in the ...
Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
What are the most exciting advances in medicine on the horizon, the ones that could prevent or treat our biggest killers like ...
How a Bay Area tech entrepreneur, the Allen Institute, the Bezos family and others are targeting neurodegenerative diseases ...
8don MSN
The World’s First ‘Reverse-Ageing’ Human Trial Has Begun — And It Could Change Medicine Forever
A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...
Scientists in Spain and Switzerland have identified a new experimental molecule that could help restore the brain’s natural defence system against Alzheimer’s disease, offering a potential new ...
A new study identifies sex-specific glioblastoma immune mechanism where GABA reprograms granulocytic MDSCs to fuel tumor growth solely in females.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results